Sykehuset Telemark HF
Skien, N-3710, Norway
NCT Number: NCT00727714
The aim of the study is to examine possible changes in lung function, nitric oxide levels and systemic inflammatory markers in cement dust exposed workers, during one shift (6-8 hours).
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Skien, N-3710, Norway
OBJECTIVE:
Cement dust is suspected to be one of the main factors causing increased mortality among workers not only in the cement production industry, but also in the construction industry worldwide. Our aim is to examine possible changes in lung function, nitric oxide levels and systemic inflammatory markers in cement dust exposed workers, during one shift (6-8 hours).
METHODS:
All employees from Norwegian cement plants, are invited to participate. The workers will perform spirometry, single-breath determination of carbon monoxide uptake, blood samples before and after a working shift of 6-8 hours, and again after 24 hours. Information on respiratory symptoms, allergy and former respiratory disease as well as exposure information will be given on a self-reported questionnaire. Changes in lung function indices, nitric oxide levels and serum inflammatory markers will be calculated. Nitric oxide will only be measured in non-smokers. We will compare cement dust exposed workers with low-level or non-exposed workers (controls).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline and 6-8h
Changes in lung function measurements during one work shift (6-8h), spirometry and gass diffusion capacity
Time frame: baseline and 6-8h
Time frame: Baseline and 6-8h
Time frame: 0-32h
Time frame: 0-32h
Sykehuset Telemark
Other Gov
Circulating Inflammatory Markers, Exhaled NO and Lung Function in Cement Production Workers; a Cross-shifts Study
Acronym: LIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06227234
Airway Obstruction, Choking
Calgary, Alberta, Canada
View Trial DetailsNCT06742476
Airway Obstruction, Respiration Disorders
Al Fayyum, Egypt
View Trial DetailsNCT06609499
Airway Obstruction, Respiration Disorders
Radom, Masovian Voivodeship, Poland
View Trial DetailsNCT05748626
Airway Obstruction, Pathological Conditions, Signs and Symptoms
Chicago, Illinois, United States
View Trial Details